- Home
- MODV vs BIVI Comparison
MODV vs BIVI Comparison
Compare MODV & BIVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MODV
- BIVI
- Stock Information
- Founded
- MODV 1996
- BIVI 2013
- Country
- MODV United States
- BIVI United States
- Employees
- MODV N/A
- BIVI N/A
- Industry
- MODV Transportation Services
- BIVI Biotechnology: Pharmaceutical Preparations
- Sector
- MODV Consumer Discretionary
- BIVI Health Care
- Exchange
- MODV Nasdaq
- BIVI Nasdaq
- Market Cap
- MODV 16.1M
- BIVI 15.1M
- IPO Year
- MODV N/A
- BIVI N/A
- Fundamental
- Price
- MODV $1.17
- BIVI $1.12
- Analyst Decision
- MODV Buy
- BIVI Strong Buy
- Analyst Count
- MODV 4
- BIVI 1
- Target Price
- MODV $8.38
- BIVI $30.00
- AVG Volume (30 Days)
- MODV 505.6K
- BIVI 777.0K
- Earning Date
- MODV 05-08-2025
- BIVI 05-20-2025
- Dividend Yield
- MODV N/A
- BIVI N/A
- EPS Growth
- MODV N/A
- BIVI N/A
- EPS
- MODV N/A
- BIVI N/A
- Revenue
- MODV $2,753,789,000.00
- BIVI N/A
- Revenue This Year
- MODV N/A
- BIVI N/A
- Revenue Next Year
- MODV $5.64
- BIVI N/A
- P/E Ratio
- MODV N/A
- BIVI N/A
- Revenue Growth
- MODV N/A
- BIVI N/A
- 52 Week Low
- MODV $0.96
- BIVI $0.62
- 52 Week High
- MODV $32.82
- BIVI $7.50
- Technical
- Relative Strength Index (RSI)
- MODV 39.11
- BIVI 56.45
- Support Level
- MODV $1.28
- BIVI $1.04
- Resistance Level
- MODV $1.54
- BIVI $1.29
- Average True Range (ATR)
- MODV 0.21
- BIVI 0.13
- MACD
- MODV 0.06
- BIVI 0.05
- Stochastic Oscillator
- MODV 29.41
- BIVI 63.57
About MODV ModivCare Inc.
ModivCare Inc is a technology-enabled healthcare services company that provides a suite of integrated supportive care solutions for payors and their members. Its solutions address the social determinants of health (SDoH) by connecting members to essential care services. Its various service offerings include non-emergency medical transportation, personal care, virtual and remote monitoring, consumer health engagement, and integrated supportive care. The company's reportable segments are NEMT, PCS, Monitoring, and Corporate and Other. A majority of its revenue is generated from the NEMT segment, which provides non-emergency medical transportation services.
About BIVI BioVie Inc.
BioVie Inc is a clinical-stage company developing drug therapies to treat chronic debilitating conditions including liver disease and neurological and neuro-degenerative disorders and certain cancers. The Company is conducting a potentially pivotal Phase 3 randomized, double-blind, placebo-controlled, parallel-group, multicenter study to evaluate NE3107 in patients who have mild to moderate Alzheimer's disease. BIV201 has the potential to improve the health of thousands of patients suffering from life-threatening complications of liver cirrhosis due to hepatitis, non-alcoholic steatohepatitis and alcoholism.